BioShares Biotechnology Clinical Trials ETF (BBC)

NYSEARCA: BBC · Delayed Price · USD
0.21 (0.72%)
At close: Jan 26, 2022 2:52 PM
-0.78 (-2.65%)
After-hours:Jan 26, 2022 6:30 PM EST
Expense Ratio0.79%
PE Ration/a
Shares Out800,000
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend DateDec 20, 2017
1-Year Return-45.94%
Previous Close29.32
Day's Range28.65 - 30.59
52-Week Low27.22
52-Week High27.22
Inception DateDec 16, 2014

About BBC

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Asset ClassPortfolio-Multi Asset
RegionNorth America
Stock ExchangeNYSEARCA
Ticker SymbolBBC
Index TrackedBioShares Biotechnology Clinical Trials Index

Top 10 Holdings

8.88% of assets
Bny Mellon Cash Reserve UsdN/A1.98%
Mirum PharmaceuticalsMIRM0.90%
Kura OncologyKURA0.82%
Prometheus BiosciencesRXDX0.76%
Stoke TherapeuticsSTOK0.74%
Xenon PharmaceuticalsXENE0.74%
Kezar Life SciencesKZR0.72%
Relmada TherapeuticsRLMD0.72%
View More Holdings


Ex-DividendAmountPay Date
Dec 20, 2017$0.29724Dec 27, 2017
Dec 21, 2015$0.14733Dec 29, 2015
Full Dividend History


Biotech M&A Could Finally Perk Up in 2022

Broadly speaking, mergers and acquisitions in the healthcare sector were steady in 2021, but for many investors, there weren't enough aimed at smaller biotechnology companies. As is often the case, mark...

Other symbols:BBHIBBSBIO
1 month ago - ETF Trends

Smaller Biotech Stocks Ready to Perk Up

If there's an asset class that's looking forward to 2022, it's small- and mid-cap (SMID) biotechnology stocks because that group dealt with a variety of headwinds this year. However, there are more reas...

Other symbols:SBIOBBHIBB
1 month ago - ETF Trends

Biotech Stocks Have Colds, but They Can Heal

This year hasn't been kind to biotechnology stocks and related exchange traded funds. The headwinds faced by these assets were ratcheted up last week when the Biden administration revealed plans to purs...

Other symbols:SBIOBBHIBB
4 months ago - ETF Trends

Finding Synergy With SPY

Looking for the perfect partner for the world's largest ETF.

4 months ago - ETFcom

Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News

The FDA granted full approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech that could accelerate inoculations in the United States.

5 months ago - Zacks Investment Research

Should Investors Follow Private Equity into Life Sciences?

Reflecting what it considers the vast potential of life sciences companies, Bain Capital is making another huge bet on the industry. The Boston-based investment firm has raised $1.9 billion in a new fun...

5 months ago - GuruFocus

Biotech ETFs Surge on Biogen's Alzheimer Drug Approval

The approval for Biogen's Alzheimer's disease treatment has spread strong optimism, with many investors pulling in capital to this high growth and high beta sector.

7 months ago - Zacks Investment Research

Healthcare ETFs Pop on Bristol Myers-MyoKardia Deal

These funds could be the best ways for investors to tap the opportunity arising from the Bristol Myers-MyoKardia deal and will likely see smooth trading in the months to come.

1 year ago - Zacks Investment Research

Healthcare ETFs, Stocks That Gained Double Digits Last Week

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

1 year ago - Zacks Investment Research

Why Small-Cap Biotech ETFs Are Good Long-Term Bets

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

Other symbols:BTECIDNA
1 year ago - Zacks Investment Research

Betting on Biotech With Utility Beyond Covid-19

The ALPS Medical Breakthroughs ETF (SBIO) is one of many biotechnology ETF garnering attention this year amid the race to defeat the coronavirus, but SBIO also offers investors allure that will extend b...

Other symbols:IBBSBIO
1 year ago - ETF Trends

Novavax's 30% surge boosts biotech ETFs to best day in weeks

Exchange-traded funds with exposure to biotech stocks rocketed higher Tuesday on hopeful news about treatments for COVID-19.

Other symbols:NVAXGERM
1 year ago - Market Watch

Biotech ETFs Gain Amid Vaccine Optimism

With a slew of news to start off the month and quarter, biotech equities and ETFs are moving higher on Wednesday with optimism over developments on the coronavirus vaccine front. The Dow Jones Industria...

Other symbols:BBHIBB
1 year ago - ETF Trends

3 ETFs With Q2 Gains Of At Least 30%

The S&P 500 is sitting on an impressive 16.36% gain with just one day left in the second quarter.

Other symbols:ACESARGT
1 year ago - Benzinga

Biotech ETFs in the Spotlight, Why They’ll Remain There

Biotechnology ETFs, including the ALPS Medical Breakthroughs ETF (SBIO), are on torrid paces in the second quarter. Yes, some of that bullishness is attributable to the industry’s efforts to vanquish th...

Other symbols:IBBSBIO
1 year ago - ETF Trends

4 Best ETF Charts of Q1 Earnings

Below are four ETFs that buoyed up on strong earnings results.

Other symbols:IBUYITBWCLD
1 year ago - Zacks Investment Research

Biotech ETF (BBC) Hits a New 52-Week High

This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

1 year ago - Zacks Investment Research

Biotechnology Sector ETFs Are Leading the Charge

Biotechnology sector-related exchange traded funds led the charge on Monday, with some breaking out to new highs. Among the best performing non-leveraged ETFs of Monday, the ARK Genomic Revolution ETF (...

Other symbols:XBI
1 year ago - ETF Trends

3 Biotech ETFs Up 10% Or More Over The Last Month

Something's been brewing in the health care sector, the second-largest group in the S&P 500.

Other symbols:ARKGBTEC
1 year ago - Benzinga

Failure to Launch: The ETF Built to Fight the Coronavirus That Never Came to Be

Bloomberg's Eric Balchunas and Scarlet Fu break down the Virtus LifeSci Biotech Clinical Trials ETF (ticker: BBC) with Paul Yook, CIO of LifeSci Venture Partners.

1 year ago - Bloomberg Markets and Finance

Best Growth ETFs for Q1 2020

The best Growth ETFs for Q1 2020 are XLK, BBC, and VGT.

Other symbols:VGTXLK
1 year ago - Investopedia

Best Healthcare ETFs for Q1 2020

The best Healthcare ETFs for Q1 2020 are BBC, SBIO, and KURE.

Other symbols:KURESBIO
1 year ago - Investopedia

Biotech ETFs Are Not Riding the Wave from Coronavirus Panic

Despite concerns of a spreading coronavirus out of China, biotechnology stocks and sector-related ETFs are not enjoying the usual bump on hopes of developing new treatments to counter the contagion. Amo...

Other symbols:IBBXBI
2 years ago - ETF Trends

3 of the Best Biotech ETFs on the Market

These biotech ETFs could be standouts again in 2020, particularly if genomics stocks rally

Other symbols:ARKGPBE
2 years ago - InvestorPlace